Somatic alterations of <i>TP53</i>,<i> ERBB2</i>,<i> PIK3CA</i> and <i>CCND1</i> are associated with chemosensitivity for breast cancers
2019 · Cancer Science · 46 citations
https://doi.org/10.1111/cas.13976
J
Junjun Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
715
Citations
12
h-index
12
i10-index
Junjun Liu is an academic researcher. The author has contributed to research in topics: PI3K/AKT/mTOR signaling in cancer & Microtubule and mitosis dynamics & Cancer-related Molecular Pathways. The author has an h-index of 12, co-authored 26 publications.
ORCID: 0000-0002-9427-1113Papers by this author
worksNiclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer
2015 · The International Journal of Biochemistry & Cell Biology · 27 citations
https://doi.org/10.1016/j.biocel.2015.11.014
Predictors of recurrence in breast cancer subtypes with negative lymph node in a Chinese population.
2014 · PubMed · 8 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat